nodes	percent_of_prediction	percent_of_DWPC	metapath
Vigabatrin—GABBR1—GPCRs, Class C Metabotropic glutamate, pheromone—CASR—atherosclerosis	0.00866	0.177	CbGpPWpGaD
Vigabatrin—GABBR1—Class C/3 (Metabotropic glutamate/pheromone receptors)—CASR—atherosclerosis	0.00395	0.0807	CbGpPWpGaD
Vigabatrin—Sinusitis—Ezetimibe—atherosclerosis	0.00288	0.00303	CcSEcCtD
Vigabatrin—Neuropathy peripheral—Simvastatin—atherosclerosis	0.00287	0.00302	CcSEcCtD
Vigabatrin—Erectile dysfunction—Niacin—atherosclerosis	0.00278	0.00292	CcSEcCtD
Vigabatrin—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.00276	0.0029	CcSEcCtD
Vigabatrin—Sinusitis—Simvastatin—atherosclerosis	0.00275	0.00289	CcSEcCtD
Vigabatrin—Erectile dysfunction—Pravastatin—atherosclerosis	0.00273	0.00287	CcSEcCtD
Vigabatrin—Oedema peripheral—Ezetimibe—atherosclerosis	0.00271	0.00285	CcSEcCtD
Vigabatrin—Connective tissue disorder—Ezetimibe—atherosclerosis	0.00271	0.00285	CcSEcCtD
Vigabatrin—Weight increased—Pravastatin—atherosclerosis	0.0027	0.00284	CcSEcCtD
Vigabatrin—Erythema multiforme—Lovastatin—atherosclerosis	0.00266	0.00279	CcSEcCtD
Vigabatrin—Depression—Pravastatin—atherosclerosis	0.00264	0.00277	CcSEcCtD
Vigabatrin—Angioedema—Rosuvastatin—atherosclerosis	0.00264	0.00277	CcSEcCtD
Vigabatrin—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.00262	0.00276	CcSEcCtD
Vigabatrin—Erythema multiforme—Ezetimibe—atherosclerosis	0.0026	0.00274	CcSEcCtD
Vigabatrin—Neuropathy peripheral—Pravastatin—atherosclerosis	0.00259	0.00273	CcSEcCtD
Vigabatrin—Urinary tract infection—Pravastatin—atherosclerosis	0.00257	0.0027	CcSEcCtD
Vigabatrin—Cough—Rosuvastatin—atherosclerosis	0.00252	0.00265	CcSEcCtD
Vigabatrin—Erythema multiforme—Simvastatin—atherosclerosis	0.00248	0.00261	CcSEcCtD
Vigabatrin—Sinusitis—Pravastatin—atherosclerosis	0.00248	0.00261	CcSEcCtD
Vigabatrin—Arthralgia—Rosuvastatin—atherosclerosis	0.00246	0.00258	CcSEcCtD
Vigabatrin—Myalgia—Rosuvastatin—atherosclerosis	0.00246	0.00258	CcSEcCtD
Vigabatrin—Mental disorder—Ezetimibe—atherosclerosis	0.00241	0.00254	CcSEcCtD
Vigabatrin—Hypoaesthesia—Niacin—atherosclerosis	0.0024	0.00252	CcSEcCtD
Vigabatrin—Malnutrition—Ezetimibe—atherosclerosis	0.0024	0.00252	CcSEcCtD
Vigabatrin—Oedema peripheral—Niacin—atherosclerosis	0.00238	0.0025	CcSEcCtD
Vigabatrin—Confusional state—Rosuvastatin—atherosclerosis	0.00237	0.0025	CcSEcCtD
Vigabatrin—Back pain—Lovastatin—atherosclerosis	0.00237	0.00249	CcSEcCtD
Vigabatrin—Hypoaesthesia—Pravastatin—atherosclerosis	0.00236	0.00248	CcSEcCtD
Vigabatrin—Muscle spasms—Lovastatin—atherosclerosis	0.00235	0.00247	CcSEcCtD
Vigabatrin—Infection—Rosuvastatin—atherosclerosis	0.00234	0.00246	CcSEcCtD
Vigabatrin—Visual impairment—Niacin—atherosclerosis	0.00232	0.00244	CcSEcCtD
Vigabatrin—Back pain—Ezetimibe—atherosclerosis	0.00232	0.00244	CcSEcCtD
Vigabatrin—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00231	0.00243	CcSEcCtD
Vigabatrin—Muscle spasms—Ezetimibe—atherosclerosis	0.00231	0.00242	CcSEcCtD
Vigabatrin—Vision blurred—Lovastatin—atherosclerosis	0.0023	0.00242	CcSEcCtD
Vigabatrin—Mental disorder—Simvastatin—atherosclerosis	0.0023	0.00242	CcSEcCtD
Vigabatrin—Tremor—Lovastatin—atherosclerosis	0.00229	0.00241	CcSEcCtD
Vigabatrin—Visual impairment—Pravastatin—atherosclerosis	0.00229	0.00241	CcSEcCtD
Vigabatrin—Ill-defined disorder—Lovastatin—atherosclerosis	0.00227	0.00239	CcSEcCtD
Vigabatrin—Eye disorder—Niacin—atherosclerosis	0.00225	0.00237	CcSEcCtD
Vigabatrin—Tinnitus—Niacin—atherosclerosis	0.00225	0.00236	CcSEcCtD
Vigabatrin—Erythema multiforme—Pravastatin—atherosclerosis	0.00225	0.00236	CcSEcCtD
Vigabatrin—Angioedema—Lovastatin—atherosclerosis	0.00223	0.00235	CcSEcCtD
Vigabatrin—Ill-defined disorder—Ezetimibe—atherosclerosis	0.00223	0.00234	CcSEcCtD
Vigabatrin—Anaemia—Ezetimibe—atherosclerosis	0.00222	0.00233	CcSEcCtD
Vigabatrin—Tinnitus—Pravastatin—atherosclerosis	0.00221	0.00233	CcSEcCtD
Vigabatrin—Malaise—Lovastatin—atherosclerosis	0.0022	0.00232	CcSEcCtD
Vigabatrin—Muscle spasms—Simvastatin—atherosclerosis	0.0022	0.00231	CcSEcCtD
Vigabatrin—Vertigo—Lovastatin—atherosclerosis	0.0022	0.00231	CcSEcCtD
Vigabatrin—Angioedema—Ezetimibe—atherosclerosis	0.00219	0.0023	CcSEcCtD
Vigabatrin—Malaise—Ezetimibe—atherosclerosis	0.00216	0.00227	CcSEcCtD
Vigabatrin—Vision blurred—Simvastatin—atherosclerosis	0.00216	0.00227	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00215	0.00226	CcSEcCtD
Vigabatrin—Tremor—Simvastatin—atherosclerosis	0.00214	0.00225	CcSEcCtD
Vigabatrin—Insomnia—Rosuvastatin—atherosclerosis	0.00213	0.00224	CcSEcCtD
Vigabatrin—Ill-defined disorder—Simvastatin—atherosclerosis	0.00212	0.00223	CcSEcCtD
Vigabatrin—Paraesthesia—Rosuvastatin—atherosclerosis	0.00211	0.00222	CcSEcCtD
Vigabatrin—Anaemia—Simvastatin—atherosclerosis	0.00211	0.00222	CcSEcCtD
Vigabatrin—Malnutrition—Niacin—atherosclerosis	0.0021	0.00221	CcSEcCtD
Vigabatrin—Cough—Ezetimibe—atherosclerosis	0.00209	0.0022	CcSEcCtD
Vigabatrin—Angioedema—Simvastatin—atherosclerosis	0.00209	0.0022	CcSEcCtD
Vigabatrin—Chest pain—Lovastatin—atherosclerosis	0.00208	0.00219	CcSEcCtD
Vigabatrin—Myalgia—Lovastatin—atherosclerosis	0.00208	0.00219	CcSEcCtD
Vigabatrin—Arthralgia—Lovastatin—atherosclerosis	0.00208	0.00219	CcSEcCtD
Vigabatrin—Anxiety—Lovastatin—atherosclerosis	0.00207	0.00218	CcSEcCtD
Vigabatrin—Dyspepsia—Rosuvastatin—atherosclerosis	0.00207	0.00218	CcSEcCtD
Vigabatrin—Malaise—Simvastatin—atherosclerosis	0.00206	0.00217	CcSEcCtD
Vigabatrin—Tension—Niacin—atherosclerosis	0.00206	0.00217	CcSEcCtD
Vigabatrin—Discomfort—Lovastatin—atherosclerosis	0.00206	0.00216	CcSEcCtD
Vigabatrin—Vertigo—Simvastatin—atherosclerosis	0.00205	0.00216	CcSEcCtD
Vigabatrin—Myalgia—Ezetimibe—atherosclerosis	0.00204	0.00215	CcSEcCtD
Vigabatrin—Chest pain—Ezetimibe—atherosclerosis	0.00204	0.00215	CcSEcCtD
Vigabatrin—Arthralgia—Ezetimibe—atherosclerosis	0.00204	0.00215	CcSEcCtD
Vigabatrin—Nervousness—Niacin—atherosclerosis	0.00204	0.00214	CcSEcCtD
Vigabatrin—Tension—Pravastatin—atherosclerosis	0.00203	0.00213	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00203	0.00213	CcSEcCtD
Vigabatrin—Muscle spasms—Niacin—atherosclerosis	0.00202	0.00212	CcSEcCtD
Vigabatrin—Discomfort—Ezetimibe—atherosclerosis	0.00202	0.00212	CcSEcCtD
Vigabatrin—Constipation—Rosuvastatin—atherosclerosis	0.00201	0.00212	CcSEcCtD
Vigabatrin—Pain—Rosuvastatin—atherosclerosis	0.00201	0.00212	CcSEcCtD
Vigabatrin—Confusional state—Lovastatin—atherosclerosis	0.00201	0.00212	CcSEcCtD
Vigabatrin—Nervousness—Pravastatin—atherosclerosis	0.00201	0.00211	CcSEcCtD
Vigabatrin—Muscle spasms—Pravastatin—atherosclerosis	0.00199	0.00209	CcSEcCtD
Vigabatrin—Infection—Lovastatin—atherosclerosis	0.00198	0.00208	CcSEcCtD
Vigabatrin—Vision blurred—Niacin—atherosclerosis	0.00198	0.00208	CcSEcCtD
Vigabatrin—Confusional state—Ezetimibe—atherosclerosis	0.00197	0.00208	CcSEcCtD
Vigabatrin—Vision blurred—Pravastatin—atherosclerosis	0.00195	0.00205	CcSEcCtD
Vigabatrin—Myalgia—Simvastatin—atherosclerosis	0.00195	0.00205	CcSEcCtD
Vigabatrin—Arthralgia—Simvastatin—atherosclerosis	0.00195	0.00205	CcSEcCtD
Vigabatrin—Chest pain—Simvastatin—atherosclerosis	0.00195	0.00205	CcSEcCtD
Vigabatrin—Infection—Ezetimibe—atherosclerosis	0.00194	0.00204	CcSEcCtD
Vigabatrin—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00194	0.00204	CcSEcCtD
Vigabatrin—Anxiety—Simvastatin—atherosclerosis	0.00194	0.00204	CcSEcCtD
Vigabatrin—Tremor—Pravastatin—atherosclerosis	0.00194	0.00204	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00193	0.00202	CcSEcCtD
Vigabatrin—Discomfort—Simvastatin—atherosclerosis	0.00192	0.00202	CcSEcCtD
Vigabatrin—Nervous system disorder—Ezetimibe—atherosclerosis	0.00192	0.00202	CcSEcCtD
Vigabatrin—Angioedema—Niacin—atherosclerosis	0.00192	0.00202	CcSEcCtD
Vigabatrin—Ill-defined disorder—Pravastatin—atherosclerosis	0.00192	0.00202	CcSEcCtD
Vigabatrin—Anaemia—Pravastatin—atherosclerosis	0.00191	0.00201	CcSEcCtD
Vigabatrin—Skin disorder—Ezetimibe—atherosclerosis	0.0019	0.002	CcSEcCtD
Vigabatrin—Angioedema—Pravastatin—atherosclerosis	0.00189	0.00199	CcSEcCtD
Vigabatrin—Vertigo—Niacin—atherosclerosis	0.00189	0.00198	CcSEcCtD
Vigabatrin—Confusional state—Simvastatin—atherosclerosis	0.00188	0.00198	CcSEcCtD
Vigabatrin—Urticaria—Rosuvastatin—atherosclerosis	0.00187	0.00197	CcSEcCtD
Vigabatrin—Oedema—Simvastatin—atherosclerosis	0.00187	0.00196	CcSEcCtD
Vigabatrin—Malaise—Pravastatin—atherosclerosis	0.00186	0.00196	CcSEcCtD
Vigabatrin—Abdominal pain—Rosuvastatin—atherosclerosis	0.00186	0.00196	CcSEcCtD
Vigabatrin—Vertigo—Pravastatin—atherosclerosis	0.00186	0.00195	CcSEcCtD
Vigabatrin—Infection—Simvastatin—atherosclerosis	0.00185	0.00195	CcSEcCtD
Vigabatrin—Cough—Niacin—atherosclerosis	0.00183	0.00193	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00182	0.00191	CcSEcCtD
Vigabatrin—Insomnia—Lovastatin—atherosclerosis	0.0018	0.0019	CcSEcCtD
Vigabatrin—Cough—Pravastatin—atherosclerosis	0.0018	0.0019	CcSEcCtD
Vigabatrin—Paraesthesia—Lovastatin—atherosclerosis	0.00179	0.00188	CcSEcCtD
Vigabatrin—Arthralgia—Niacin—atherosclerosis	0.00179	0.00188	CcSEcCtD
Vigabatrin—Myalgia—Niacin—atherosclerosis	0.00179	0.00188	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00178	0.00187	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00178	0.00187	CcSEcCtD
Vigabatrin—Insomnia—Ezetimibe—atherosclerosis	0.00177	0.00186	CcSEcCtD
Vigabatrin—Arthralgia—Pravastatin—atherosclerosis	0.00176	0.00185	CcSEcCtD
Vigabatrin—Myalgia—Pravastatin—atherosclerosis	0.00176	0.00185	CcSEcCtD
Vigabatrin—Chest pain—Pravastatin—atherosclerosis	0.00176	0.00185	CcSEcCtD
Vigabatrin—Paraesthesia—Ezetimibe—atherosclerosis	0.00176	0.00185	CcSEcCtD
Vigabatrin—Dyspepsia—Lovastatin—atherosclerosis	0.00176	0.00185	CcSEcCtD
Vigabatrin—Anxiety—Pravastatin—atherosclerosis	0.00175	0.00184	CcSEcCtD
Vigabatrin—Discomfort—Pravastatin—atherosclerosis	0.00174	0.00183	CcSEcCtD
Vigabatrin—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00173	0.00182	CcSEcCtD
Vigabatrin—Decreased appetite—Lovastatin—atherosclerosis	0.00173	0.00182	CcSEcCtD
Vigabatrin—Dyspepsia—Ezetimibe—atherosclerosis	0.00172	0.00181	CcSEcCtD
Vigabatrin—Fatigue—Lovastatin—atherosclerosis	0.00172	0.00181	CcSEcCtD
Vigabatrin—Oedema—Niacin—atherosclerosis	0.00171	0.0018	CcSEcCtD
Vigabatrin—Constipation—Lovastatin—atherosclerosis	0.00171	0.00179	CcSEcCtD
Vigabatrin—Pain—Lovastatin—atherosclerosis	0.00171	0.00179	CcSEcCtD
Vigabatrin—Confusional state—Pravastatin—atherosclerosis	0.0017	0.00179	CcSEcCtD
Vigabatrin—Decreased appetite—Ezetimibe—atherosclerosis	0.0017	0.00179	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.0017	0.00179	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00169	0.00178	CcSEcCtD
Vigabatrin—Asthenia—Rosuvastatin—atherosclerosis	0.00169	0.00178	CcSEcCtD
Vigabatrin—Insomnia—Simvastatin—atherosclerosis	0.00169	0.00178	CcSEcCtD
Vigabatrin—Oedema—Pravastatin—atherosclerosis	0.00169	0.00177	CcSEcCtD
Vigabatrin—Fatigue—Ezetimibe—atherosclerosis	0.00169	0.00177	CcSEcCtD
Vigabatrin—Infection—Pravastatin—atherosclerosis	0.00168	0.00176	CcSEcCtD
Vigabatrin—Paraesthesia—Simvastatin—atherosclerosis	0.00168	0.00176	CcSEcCtD
Vigabatrin—Pain—Ezetimibe—atherosclerosis	0.00167	0.00176	CcSEcCtD
Vigabatrin—Constipation—Ezetimibe—atherosclerosis	0.00167	0.00176	CcSEcCtD
Vigabatrin—Pruritus—Rosuvastatin—atherosclerosis	0.00167	0.00175	CcSEcCtD
Vigabatrin—Skin disorder—Niacin—atherosclerosis	0.00166	0.00175	CcSEcCtD
Vigabatrin—Feeling abnormal—Lovastatin—atherosclerosis	0.00164	0.00173	CcSEcCtD
Vigabatrin—Dyspepsia—Simvastatin—atherosclerosis	0.00164	0.00173	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00163	0.00172	CcSEcCtD
Vigabatrin—Decreased appetite—Simvastatin—atherosclerosis	0.00162	0.00171	CcSEcCtD
Vigabatrin—Feeling abnormal—Ezetimibe—atherosclerosis	0.00161	0.0017	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00161	0.00169	CcSEcCtD
Vigabatrin—Diarrhoea—Rosuvastatin—atherosclerosis	0.00161	0.00169	CcSEcCtD
Vigabatrin—Fatigue—Simvastatin—atherosclerosis	0.00161	0.00169	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.0016	0.00168	CcSEcCtD
Vigabatrin—Constipation—Simvastatin—atherosclerosis	0.0016	0.00168	CcSEcCtD
Vigabatrin—Pain—Simvastatin—atherosclerosis	0.0016	0.00168	CcSEcCtD
Vigabatrin—Urticaria—Lovastatin—atherosclerosis	0.00159	0.00167	CcSEcCtD
Vigabatrin—Abdominal pain—Lovastatin—atherosclerosis	0.00158	0.00166	CcSEcCtD
Vigabatrin—Body temperature increased—Lovastatin—atherosclerosis	0.00158	0.00166	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00156	0.00164	CcSEcCtD
Vigabatrin—Dizziness—Rosuvastatin—atherosclerosis	0.00156	0.00164	CcSEcCtD
Vigabatrin—Urticaria—Ezetimibe—atherosclerosis	0.00155	0.00163	CcSEcCtD
Vigabatrin—Insomnia—Niacin—atherosclerosis	0.00155	0.00163	CcSEcCtD
Vigabatrin—Abdominal pain—Ezetimibe—atherosclerosis	0.00155	0.00163	CcSEcCtD
Vigabatrin—Body temperature increased—Ezetimibe—atherosclerosis	0.00155	0.00163	CcSEcCtD
Vigabatrin—Paraesthesia—Niacin—atherosclerosis	0.00154	0.00162	CcSEcCtD
Vigabatrin—Feeling abnormal—Simvastatin—atherosclerosis	0.00154	0.00162	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00154	0.00162	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00153	0.0016	CcSEcCtD
Vigabatrin—Insomnia—Pravastatin—atherosclerosis	0.00153	0.0016	CcSEcCtD
Vigabatrin—Somnolence—Niacin—atherosclerosis	0.00152	0.0016	CcSEcCtD
Vigabatrin—Paraesthesia—Pravastatin—atherosclerosis	0.00152	0.00159	CcSEcCtD
Vigabatrin—Dyspepsia—Niacin—atherosclerosis	0.00151	0.00159	CcSEcCtD
Vigabatrin—Decreased appetite—Niacin—atherosclerosis	0.00149	0.00157	CcSEcCtD
Vigabatrin—Dyspepsia—Pravastatin—atherosclerosis	0.00149	0.00156	CcSEcCtD
Vigabatrin—Rash—Rosuvastatin—atherosclerosis	0.00148	0.00156	CcSEcCtD
Vigabatrin—Dermatitis—Rosuvastatin—atherosclerosis	0.00148	0.00156	CcSEcCtD
Vigabatrin—Urticaria—Simvastatin—atherosclerosis	0.00148	0.00156	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Niacin—atherosclerosis	0.00148	0.00156	CcSEcCtD
Vigabatrin—Body temperature increased—Simvastatin—atherosclerosis	0.00148	0.00155	CcSEcCtD
Vigabatrin—Abdominal pain—Simvastatin—atherosclerosis	0.00148	0.00155	CcSEcCtD
Vigabatrin—Headache—Rosuvastatin—atherosclerosis	0.00148	0.00155	CcSEcCtD
Vigabatrin—Hypersensitivity—Lovastatin—atherosclerosis	0.00147	0.00155	CcSEcCtD
Vigabatrin—Decreased appetite—Pravastatin—atherosclerosis	0.00147	0.00154	CcSEcCtD
Vigabatrin—Pain—Niacin—atherosclerosis	0.00147	0.00154	CcSEcCtD
Vigabatrin—Fatigue—Pravastatin—atherosclerosis	0.00145	0.00153	CcSEcCtD
Vigabatrin—Pain—Pravastatin—atherosclerosis	0.00144	0.00152	CcSEcCtD
Vigabatrin—Constipation—Pravastatin—atherosclerosis	0.00144	0.00152	CcSEcCtD
Vigabatrin—Hypersensitivity—Ezetimibe—atherosclerosis	0.00144	0.00152	CcSEcCtD
Vigabatrin—Asthenia—Lovastatin—atherosclerosis	0.00143	0.00151	CcSEcCtD
Vigabatrin—Pruritus—Lovastatin—atherosclerosis	0.00141	0.00148	CcSEcCtD
Vigabatrin—Asthenia—Ezetimibe—atherosclerosis	0.0014	0.00148	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Niacin—atherosclerosis	0.0014	0.00147	CcSEcCtD
Vigabatrin—Nausea—Rosuvastatin—atherosclerosis	0.0014	0.00147	CcSEcCtD
Vigabatrin—Feeling abnormal—Pravastatin—atherosclerosis	0.00139	0.00146	CcSEcCtD
Vigabatrin—Pruritus—Ezetimibe—atherosclerosis	0.00138	0.00146	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00138	0.00145	CcSEcCtD
Vigabatrin—Hypersensitivity—Simvastatin—atherosclerosis	0.00138	0.00145	CcSEcCtD
Vigabatrin—Diarrhoea—Lovastatin—atherosclerosis	0.00137	0.00144	CcSEcCtD
Vigabatrin—Urticaria—Niacin—atherosclerosis	0.00136	0.00143	CcSEcCtD
Vigabatrin—Abdominal pain—Niacin—atherosclerosis	0.00135	0.00142	CcSEcCtD
Vigabatrin—Body temperature increased—Niacin—atherosclerosis	0.00135	0.00142	CcSEcCtD
Vigabatrin—Urticaria—Pravastatin—atherosclerosis	0.00134	0.00141	CcSEcCtD
Vigabatrin—Asthenia—Simvastatin—atherosclerosis	0.00134	0.00141	CcSEcCtD
Vigabatrin—Diarrhoea—Ezetimibe—atherosclerosis	0.00134	0.00141	CcSEcCtD
Vigabatrin—Body temperature increased—Pravastatin—atherosclerosis	0.00133	0.0014	CcSEcCtD
Vigabatrin—Abdominal pain—Pravastatin—atherosclerosis	0.00133	0.0014	CcSEcCtD
Vigabatrin—Pruritus—Simvastatin—atherosclerosis	0.00132	0.00139	CcSEcCtD
Vigabatrin—Dizziness—Lovastatin—atherosclerosis	0.00132	0.00139	CcSEcCtD
Vigabatrin—Dizziness—Ezetimibe—atherosclerosis	0.00129	0.00136	CcSEcCtD
Vigabatrin—Diarrhoea—Simvastatin—atherosclerosis	0.00128	0.00134	CcSEcCtD
Vigabatrin—Vomiting—Lovastatin—atherosclerosis	0.00127	0.00133	CcSEcCtD
Vigabatrin—Hypersensitivity—Niacin—atherosclerosis	0.00126	0.00133	CcSEcCtD
Vigabatrin—Rash—Lovastatin—atherosclerosis	0.00126	0.00132	CcSEcCtD
Vigabatrin—Dermatitis—Lovastatin—atherosclerosis	0.00126	0.00132	CcSEcCtD
Vigabatrin—Headache—Lovastatin—atherosclerosis	0.00125	0.00131	CcSEcCtD
Vigabatrin—Vomiting—Ezetimibe—atherosclerosis	0.00124	0.00131	CcSEcCtD
Vigabatrin—Hypersensitivity—Pravastatin—atherosclerosis	0.00124	0.00131	CcSEcCtD
Vigabatrin—Dizziness—Simvastatin—atherosclerosis	0.00123	0.0013	CcSEcCtD
Vigabatrin—Rash—Ezetimibe—atherosclerosis	0.00123	0.0013	CcSEcCtD
Vigabatrin—Dermatitis—Ezetimibe—atherosclerosis	0.00123	0.0013	CcSEcCtD
Vigabatrin—Asthenia—Niacin—atherosclerosis	0.00123	0.00129	CcSEcCtD
Vigabatrin—Headache—Ezetimibe—atherosclerosis	0.00123	0.00129	CcSEcCtD
Vigabatrin—Pruritus—Niacin—atherosclerosis	0.00121	0.00127	CcSEcCtD
Vigabatrin—Asthenia—Pravastatin—atherosclerosis	0.00121	0.00127	CcSEcCtD
Vigabatrin—Pruritus—Pravastatin—atherosclerosis	0.00119	0.00126	CcSEcCtD
Vigabatrin—Vomiting—Simvastatin—atherosclerosis	0.00119	0.00125	CcSEcCtD
Vigabatrin—Nausea—Lovastatin—atherosclerosis	0.00119	0.00125	CcSEcCtD
Vigabatrin—Rash—Simvastatin—atherosclerosis	0.00118	0.00124	CcSEcCtD
Vigabatrin—Dermatitis—Simvastatin—atherosclerosis	0.00118	0.00124	CcSEcCtD
Vigabatrin—Diarrhoea—Niacin—atherosclerosis	0.00117	0.00123	CcSEcCtD
Vigabatrin—Headache—Simvastatin—atherosclerosis	0.00117	0.00123	CcSEcCtD
Vigabatrin—Nausea—Ezetimibe—atherosclerosis	0.00116	0.00122	CcSEcCtD
Vigabatrin—Diarrhoea—Pravastatin—atherosclerosis	0.00115	0.00121	CcSEcCtD
Vigabatrin—Dizziness—Niacin—atherosclerosis	0.00113	0.00119	CcSEcCtD
Vigabatrin—Dizziness—Pravastatin—atherosclerosis	0.00112	0.00117	CcSEcCtD
Vigabatrin—Nausea—Simvastatin—atherosclerosis	0.00111	0.00117	CcSEcCtD
Vigabatrin—Vomiting—Niacin—atherosclerosis	0.00109	0.00115	CcSEcCtD
Vigabatrin—Rash—Niacin—atherosclerosis	0.00108	0.00114	CcSEcCtD
Vigabatrin—Dermatitis—Niacin—atherosclerosis	0.00108	0.00114	CcSEcCtD
Vigabatrin—Headache—Niacin—atherosclerosis	0.00107	0.00113	CcSEcCtD
Vigabatrin—Vomiting—Pravastatin—atherosclerosis	0.00107	0.00113	CcSEcCtD
Vigabatrin—Rash—Pravastatin—atherosclerosis	0.00106	0.00112	CcSEcCtD
Vigabatrin—Dermatitis—Pravastatin—atherosclerosis	0.00106	0.00112	CcSEcCtD
Vigabatrin—Headache—Pravastatin—atherosclerosis	0.00106	0.00111	CcSEcCtD
Vigabatrin—Nausea—Niacin—atherosclerosis	0.00102	0.00107	CcSEcCtD
Vigabatrin—Nausea—Pravastatin—atherosclerosis	0.001	0.00105	CcSEcCtD
Vigabatrin—GABBR1—G alpha (i) signalling events—CASR—atherosclerosis	0.000958	0.0196	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—HRH1—atherosclerosis	0.000939	0.0192	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—ABCG4—atherosclerosis	0.000892	0.0182	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—CNR2—atherosclerosis	0.000891	0.0182	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—ABCG8—atherosclerosis	0.000855	0.0175	CbGpPWpGaD
Vigabatrin—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCG—atherosclerosis	0.000713	0.0146	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—CCR2—atherosclerosis	0.000693	0.0142	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—CCL4—atherosclerosis	0.000679	0.0139	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—ABCG1—atherosclerosis	0.000676	0.0138	CbGpPWpGaD
Vigabatrin—ABAT—Transmission across Chemical Synapses—PRKCG—atherosclerosis	0.00063	0.0129	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	0.000613	0.0125	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—UTS2—atherosclerosis	0.000605	0.0124	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—KNG1—atherosclerosis	0.000592	0.0121	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—CX3CR1—atherosclerosis	0.00058	0.0119	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—CASR—atherosclerosis	0.00058	0.0119	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—CX3CL1—atherosclerosis	0.000569	0.0116	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—TRPV1—atherosclerosis	0.000551	0.0113	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—CNR2—atherosclerosis	0.000539	0.011	CbGpPWpGaD
Vigabatrin—GABBR1—Transmission across Chemical Synapses—PRKCG—atherosclerosis	0.000536	0.011	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—HRH1—atherosclerosis	0.000531	0.0108	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—ABCG5—atherosclerosis	0.00053	0.0108	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—CCL5—atherosclerosis	0.000495	0.0101	CbGpPWpGaD
Vigabatrin—ABAT—Neuronal System—PRKCG—atherosclerosis	0.000483	0.00987	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—HRH1—atherosclerosis	0.000482	0.00985	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—CCL3—atherosclerosis	0.000464	0.00948	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—EDNRA—atherosclerosis	0.000419	0.00857	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—CCR2—atherosclerosis	0.000419	0.00857	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—AGT—atherosclerosis	0.000414	0.00847	CbGpPWpGaD
Vigabatrin—GABBR1—Neuronal System—PRKCG—atherosclerosis	0.000411	0.00839	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—GHRL—atherosclerosis	0.000409	0.00835	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—CETP—atherosclerosis	0.000392	0.00802	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—KNG1—atherosclerosis	0.000359	0.00733	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—AGTR1—atherosclerosis	0.000357	0.00729	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CCL4—atherosclerosis	0.000348	0.00712	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—PLAT—atherosclerosis	0.000346	0.00707	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—UTS2—atherosclerosis	0.000342	0.00699	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—CASR—atherosclerosis	0.000328	0.0067	CbGpPWpGaD
Vigabatrin—SLC36A1—SLC-mediated transmembrane transport—ALB—atherosclerosis	0.000321	0.00655	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—UTS2—atherosclerosis	0.00031	0.00635	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—CNR2—atherosclerosis	0.000305	0.00623	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—EDN1—atherosclerosis	0.000302	0.00618	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—CCL5—atherosclerosis	0.0003	0.00613	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CX3CR1—atherosclerosis	0.000298	0.00608	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CASR—atherosclerosis	0.000298	0.00608	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—PLG—atherosclerosis	0.000294	0.00601	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CX3CL1—atherosclerosis	0.000292	0.00597	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—HRH1—atherosclerosis	0.000285	0.00582	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CNR2—atherosclerosis	0.000277	0.00566	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	0.000271	0.00555	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—CXCL8—atherosclerosis	0.00027	0.00552	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—APOB—atherosclerosis	0.00026	0.00531	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—AGT—atherosclerosis	0.000251	0.00513	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CCL3—atherosclerosis	0.000238	0.00486	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—EDNRA—atherosclerosis	0.000237	0.00484	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—CCR2—atherosclerosis	0.000237	0.00484	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—F2—atherosclerosis	0.000232	0.00474	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—GHRL—atherosclerosis	0.000231	0.00472	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—APOA4—atherosclerosis	0.000223	0.00457	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—PPARA—atherosclerosis	0.000219	0.00448	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—EDNRA—atherosclerosis	0.000215	0.0044	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CCR2—atherosclerosis	0.000215	0.0044	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—GHRL—atherosclerosis	0.00021	0.00429	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—CCL2—atherosclerosis	0.000207	0.00422	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CCL4—atherosclerosis	0.000206	0.00421	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—APOA1—atherosclerosis	0.000206	0.0042	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—KNG1—atherosclerosis	0.000203	0.00414	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—AGTR1—atherosclerosis	0.000202	0.00412	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—APOA2—atherosclerosis	0.000192	0.00393	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—KNG1—atherosclerosis	0.000184	0.00376	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—UTS2—atherosclerosis	0.000183	0.00375	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—AGTR1—atherosclerosis	0.000183	0.00374	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CX3CR1—atherosclerosis	0.000176	0.00359	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CASR—atherosclerosis	0.000176	0.00359	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CX3CL1—atherosclerosis	0.000172	0.00352	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—EDN1—atherosclerosis	0.000171	0.00349	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—CCL5—atherosclerosis	0.00017	0.00346	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CNR2—atherosclerosis	0.000163	0.00334	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—CXCL8—atherosclerosis	0.000163	0.00334	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—MMP3—atherosclerosis	0.000163	0.00333	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—ALB—atherosclerosis	0.000163	0.00333	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—PRKCG—atherosclerosis	0.000161	0.00329	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—EDN1—atherosclerosis	0.000155	0.00317	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CCL5—atherosclerosis	0.000154	0.00315	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—PRKCG—atherosclerosis	0.000146	0.00299	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—VWF—atherosclerosis	0.000146	0.00298	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—APOC3—atherosclerosis	0.000145	0.00296	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—LDLR—atherosclerosis	0.000144	0.00294	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—AGT—atherosclerosis	0.000142	0.0029	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CCL3—atherosclerosis	0.000141	0.00287	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—NCF1—atherosclerosis	0.000135	0.00275	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—F2—atherosclerosis	0.000131	0.00268	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—AGT—atherosclerosis	0.000129	0.00263	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—EDNRA—atherosclerosis	0.000127	0.0026	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CCR2—atherosclerosis	0.000127	0.0026	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CYBA—atherosclerosis	0.000127	0.00259	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000125	0.00256	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—GHRL—atherosclerosis	0.000124	0.00253	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PLAT—atherosclerosis	0.000124	0.00253	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PARP1—atherosclerosis	0.000124	0.00253	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—F2—atherosclerosis	0.000119	0.00243	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—PIK3CG—atherosclerosis	0.000114	0.00233	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—KNG1—atherosclerosis	0.000109	0.00222	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—AGTR1—atherosclerosis	0.000108	0.00221	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CCL2—atherosclerosis	0.000106	0.00217	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PLG—atherosclerosis	0.000105	0.00215	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—SOCS3—atherosclerosis	9.98e-05	0.00204	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—MMP3—atherosclerosis	9.63e-05	0.00197	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—IGF2—atherosclerosis	9.59e-05	0.00196	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—APOB—atherosclerosis	9.31e-05	0.0019	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—CXCL8—atherosclerosis	9.23e-05	0.00189	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—EDN1—atherosclerosis	9.16e-05	0.00187	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CCL5—atherosclerosis	9.09e-05	0.00186	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—LPL—atherosclerosis	8.89e-05	0.00182	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PRKCG—atherosclerosis	8.65e-05	0.00177	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—SPP1—atherosclerosis	8.42e-05	0.00172	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CXCL8—atherosclerosis	8.38e-05	0.00171	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PDGFB—atherosclerosis	7.79e-05	0.00159	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—AGT—atherosclerosis	7.61e-05	0.00155	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—APOE—atherosclerosis	7.45e-05	0.00152	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—LEP—atherosclerosis	7.45e-05	0.00152	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CAV1—atherosclerosis	7.38e-05	0.00151	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—APOA1—atherosclerosis	7.37e-05	0.00151	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—ESR1—atherosclerosis	7.12e-05	0.00145	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—F2—atherosclerosis	7.03e-05	0.00144	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PIK3CG—atherosclerosis	6.73e-05	0.00137	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—MAPK3—atherosclerosis	6.44e-05	0.00132	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—INS—atherosclerosis	6.37e-05	0.0013	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CCL2—atherosclerosis	6.26e-05	0.00128	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—IGF1—atherosclerosis	6.16e-05	0.00126	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—SERPINE1—atherosclerosis	5.85e-05	0.0012	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—NOS3—atherosclerosis	5.58e-05	0.00114	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CXCL8—atherosclerosis	4.95e-05	0.00101	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—AKT1—atherosclerosis	4.78e-05	0.000978	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—IL6—atherosclerosis	4.71e-05	0.000963	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—MMP9—atherosclerosis	4.48e-05	0.000916	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—NFKB1—atherosclerosis	4.43e-05	0.000906	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—MAPK8—atherosclerosis	4.36e-05	0.000891	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—AKT1—atherosclerosis	4.34e-05	0.000888	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—VEGFA—atherosclerosis	4.02e-05	0.000822	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—STAT3—atherosclerosis	3.98e-05	0.000814	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—MAPK3—atherosclerosis	3.81e-05	0.000778	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—TGFB1—atherosclerosis	3.69e-05	0.000755	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—IL6—atherosclerosis	2.78e-05	0.000569	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—AKT1—atherosclerosis	2.57e-05	0.000525	CbGpPWpGaD
